NASDAQ:MASI 15 November 2025

Masimo Stock Is Stuck Just Below Danaher’s $180 Bid. The Gap Is the Story
··

Masimo Stock Is Stuck Just Below Danaher’s $180 Bid. The Gap Is the Story

Masimo Corp shares were little changed before Thursday’s open, holding just under Danaher’s $180-a-share cash offer as investors waited for the remaining approvals needed to close the medical-device takeover. The stock was last quoted at $178.78, up 5 cents from its prior close, leaving a narrow deal spread — the gap between the market price and takeover price — of about $1.22 a share, or roughly 0.7%. That spread is now the main trade in Masimo.
June 4, 2026
Apple Hit With $634 Million Masimo Verdict as Trade Tribunal Reopens Probe Into Apple Watch Blood Oxygen Feature
···

Apple Hit With $634 Million Masimo Verdict as Trade Tribunal Reopens Probe Into Apple Watch Blood Oxygen Feature

Apple is facing one of the most consequential days yet in its long-running health‑tech battle with Masimo. A federal jury in California has ordered the iPhone maker to pay $634 million for infringing a Masimo patent tied to blood‑oxygen monitoring in the Apple Watch, even as the U.S. International Trade Commission launches a fresh inquiry into Apple’s redesigned blood oxygen feature — potentially putting new Apple Watch models at risk of another import ban. Reuters+1 On Friday, November 14, 2025, a federal jury in Santa Ana, California, ruled that Apple must pay Masimo $634 million for infringing a patent that covers aspects of light‑based pulse‑oximetry — the technology used to estimate blood‑oxygen levels — in certain Apple Watch models. Reuters+1
November 15, 2025